Correlation Between TG Therapeutics and Brilliant Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Brilliant Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Brilliant Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Brilliant Acquisition Corp, you can compare the effects of market volatilities on TG Therapeutics and Brilliant Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Brilliant Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Brilliant Acquisition.

Diversification Opportunities for TG Therapeutics and Brilliant Acquisition

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between TGTX and Brilliant is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Brilliant Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brilliant Acquisition and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Brilliant Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brilliant Acquisition has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Brilliant Acquisition go up and down completely randomly.

Pair Corralation between TG Therapeutics and Brilliant Acquisition

If you would invest  1,779  in TG Therapeutics on September 26, 2024 and sell it today you would earn a total of  1,437  from holding TG Therapeutics or generate 80.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy0.8%
ValuesDaily Returns

TG Therapeutics  vs.  Brilliant Acquisition Corp

 Performance 
       Timeline  
TG Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Brilliant Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Brilliant Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong essential indicators, Brilliant Acquisition is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

TG Therapeutics and Brilliant Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TG Therapeutics and Brilliant Acquisition

The main advantage of trading using opposite TG Therapeutics and Brilliant Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Brilliant Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brilliant Acquisition will offset losses from the drop in Brilliant Acquisition's long position.
The idea behind TG Therapeutics and Brilliant Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas